China State FDA Grants Clinical Trial Approval For Celsion's Phase III Liver Cancer Trials
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA granted clinical trial approval to Columbia, Md.-based Celsion to conduct Phase III trials in China as part of the company's global trial program for leading product ThermoDo.